A citation-based method for searching scientific literature

James M Joers, Dinesh K Deelchand, Tianmeng Lyu, Uzay E Emir, Diane Hutter, Christopher M Gomez, Khalaf O Bushara, Lynn E Eberly, Gülin Öz. Ann Neurol 2018
Times Cited: 34







List of co-cited articles
467 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6.
Kathrin Reetz, Ana S Costa, Shahram Mirzazade, Anna Lehmann, Agnes Juzek, Maria Rakowicz, Romana Boguslawska, Ludger Schöls, Christoph Linnemann, Caterina Mariotti,[...]. Brain 2013
81
52

In vivo neurometabolic profiling in patients with spinocerebellar ataxia types 1, 2, 3, and 7.
Isaac M Adanyeguh, Pierre-Gilles Henry, Tra M Nguyen, Daisy Rinaldi, Celine Jauffret, Romain Valabregue, Uzay E Emir, Dinesh K Deelchand, Alexis Brice, Lynn E Eberly,[...]. Mov Disord 2015
40
47

Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data.
Heike Jacobi, Kathrin Reetz, Sophie Tezenas du Montcel, Peter Bauer, Caterina Mariotti, Lorenzo Nanetti, Maria Rakowicz, Anna Sulek, Alexandra Durr, Perrine Charles,[...]. Lancet Neurol 2013
105
44

Visualization, quantification and correlation of brain atrophy with clinical symptoms in spinocerebellar ataxia types 1, 3 and 6.
Jörg B Schulz, Johannes Borkert, Stefanie Wolf, Tanja Schmitz-Hübsch, Maryla Rakowicz, Caterina Mariotti, Ludger Schöls, Dagmar Timmann, Bart van de Warrenburg, Alexandra Dürr,[...]. Neuroimage 2010
108
35

Scale for the assessment and rating of ataxia: development of a new clinical scale.
T Schmitz-Hübsch, S Tezenas du Montcel, L Baliko, J Berciano, S Boesch, C Depondt, P Giunti, C Globas, J Infante, J-S Kang,[...]. Neurology 2006
907
35

Neurochemical alterations in spinocerebellar ataxia type 1 and their correlations with clinical status.
Gülin Oz, Diane Hutter, Ivan Tkác, H Brent Clark, Myron D Gross, Hong Jiang, Lynn E Eberly, Khalaf O Bushara, Christopher M Gomez. Mov Disord 2010
66
32

Two-site reproducibility of cerebellar and brainstem neurochemical profiles with short-echo, single-voxel MRS at 3T.
Dinesh K Deelchand, Isaac M Adanyeguh, Uzay E Emir, Tra-My Nguyen, Romain Valabregue, Pierre-Gilles Henry, Fanny Mochel, Gülin Öz. Magn Reson Med 2015
60
32

Autosomal dominant cerebellar ataxias: Imaging biomarkers with high effect sizes.
Isaac M Adanyeguh, Vincent Perlbarg, Pierre-Gilles Henry, Daisy Rinaldi, Elodie Petit, Romain Valabregue, Alexis Brice, Alexandra Durr, Fanny Mochel. Neuroimage Clin 2018
37
32

Spinocerebellar ataxias: prospects and challenges for therapy development.
Tetsuo Ashizawa, Gülin Öz, Henry L Paulson. Nat Rev Neurol 2018
70
32

Polyglutamine spinocerebellar ataxias - from genes to potential treatments.
Henry L Paulson, Vikram G Shakkottai, H Brent Clark, Harry T Orr. Nat Rev Neurosci 2017
128
29

A multimodal evaluation of microstructural white matter damage in spinocerebellar ataxia type 3.
Rachel P Guimarães, Anelyssa D'Abreu, Clarissa L Yasuda, Marcondes C França, Beatriz H B Silva, Fabio A M Cappabianco, Felipe P G Bergo, Iscia T Lopes-Cendes, Fernando Cendes. Mov Disord 2013
47
26

Antisense oligonucleotide therapy for spinocerebellar ataxia type 2.
Daniel R Scoles, Pratap Meera, Matthew D Schneider, Sharan Paul, Warunee Dansithong, Karla P Figueroa, Gene Hung, Frank Rigo, C Frank Bennett, Thomas S Otis,[...]. Nature 2017
140
26

Distinct neurochemical profiles of spinocerebellar ataxias 1, 2, 6, and cerebellar multiple system atrophy.
Gülin Oz, Isabelle Iltis, Diane Hutter, William Thomas, Khalaf O Bushara, Christopher M Gomez. Cerebellum 2011
45
26


Oligonucleotide therapy mitigates disease in spinocerebellar ataxia type 3 mice.
Hayley S McLoughlin, Lauren R Moore, Ravi Chopra, Robert Komlo, Megan McKenzie, Kate G Blumenstein, Hien Zhao, Holly B Kordasiewicz, Vikram G Shakkottai, Henry L Paulson. Ann Neurol 2018
58
26

Brain pathology of spinocerebellar ataxias.
Kay Seidel, Sonny Siswanto, Ewout R P Brunt, Wilfred den Dunnen, Horst-Werner Korf, Udo Rüb. Acta Neuropathol 2012
207
26

Structural signature of SCA3: From presymptomatic to late disease stages.
Thiago Junqueira Ribeiro Rezende, Jean Levi Ribeiro de Paiva, Alberto Rolim Muro Martinez, Iscia Lopes-Cendes, José Luiz Pedroso, Orlando Graziani Povoas Barsottini, Fernando Cendes, Marcondes C França. Ann Neurol 2018
34
26

Antisense Oligonucleotide-Mediated Removal of the Polyglutamine Repeat in Spinocerebellar Ataxia Type 3 Mice.
Lodewijk J A Toonen, Frank Rigo, Haico van Attikum, Willeke M C van Roon-Mom. Mol Ther Nucleic Acids 2017
49
23

Noninvasive detection of presymptomatic and progressive neurodegeneration in a mouse model of spinocerebellar ataxia type 1.
Gülin Oz, Christopher D Nelson, Dee M Koski, Pierre-Gilles Henry, Malgorzata Marjanska, Dinesh K Deelchand, Ryan Shanley, Lynn E Eberly, Harry T Orr, H Brent Clark. J Neurosci 2010
58
23

The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies.
Luis Ruano, Claudia Melo, M Carolina Silva, Paula Coutinho. Neuroepidemiology 2014
243
23

Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study.
Heike Jacobi, Sophie Tezenas du Montcel, Peter Bauer, Paola Giunti, Arron Cook, Robyn Labrum, Michael H Parkinson, Alexandra Durr, Alexis Brice, Perrine Charles,[...]. Lancet Neurol 2015
108
23

Brainstem neurodegeneration correlates with clinical dysfunction in SCA1 but not in SCA2. A quantitative volumetric, diffusion and proton spectroscopy MR study.
L Guerrini, F Lolli, A Ginestroni, G Belli, R Della Nave, C Tessa, S Foresti, M Cosottini, S Piacentini, F Salvi,[...]. Brain 2004
78
23

Brain atrophy measures in preclinical and manifest spinocerebellar ataxia type 2.
Kathrin Reetz, Roberto Rodríguez-Labrada, Imis Dogan, Shahram Mirzazade, Sandro Romanzetti, Jörg B Schulz, Edilia M Cruz-Rivas, Jose A Alvarez-Cuesta, Raul Aguilera Rodríguez, Yanetza Gonzalez Zaldivar,[...]. Ann Clin Transl Neurol 2018
25
32


Neocortical atrophy in Machado-Joseph disease: a longitudinal neuroimaging study.
Anelyssa D'Abreu, Marcondes C França, Clarissa L Yasuda, Bruno A G Campos, Iscia Lopes-Cendes, Fernando Cendes. J Neuroimaging 2012
54
20

Peripheral Oxidative Stress Biomarkers in Spinocerebellar Ataxia Type 3/Machado-Joseph Disease.
Adriano M de Assis, Jonas Alex Morales Saute, Aline Longoni, Clarissa Branco Haas, Vitor Rocco Torrez, Andressa Wigner Brochier, Gabriele Nunes Souza, Gabriel Vasata Furtado, Tailise Conte Gheno, Aline Russo,[...]. Front Neurol 2017
25
28

Evaluation of Antisense Oligonucleotides Targeting ATXN3 in SCA3 Mouse Models.
Lauren R Moore, Gautam Rajpal, Ian T Dillingham, Maya Qutob, Kate G Blumenstein, Danielle Gattis, Gene Hung, Holly B Kordasiewicz, Henry L Paulson, Hayley S McLoughlin. Mol Ther Nucleic Acids 2017
61
20

Early Cerebellar Network Shifting in Spinocerebellar Ataxia Type 6.
M I Falcon, C M Gomez, E E Chen, A Shereen, A Solodkin. Cereb Cortex 2016
24
29

Structural and functional MRI abnormalities of cerebellar cortex and nuclei in SCA3, SCA6 and Friedreich's ataxia.
Maria R Stefanescu, Moritz Dohnalek, Stefan Maderwald, Markus Thürling, Martina Minnerop, Andreas Beck, Marc Schlamann, Joern Diedrichsen, Mark E Ladd, Dagmar Timmann. Brain 2015
55
20

Serum neurofilament light is increased in multiple system atrophy of cerebellar type and in repeat-expansion spinocerebellar ataxias: a pilot study.
Carlo Wilke, Friedemann Bender, Stefanie N Hayer, Kathrin Brockmann, Ludger Schöls, Jens Kuhle, Matthis Synofzik. J Neurol 2018
32
21

Clinical features, neurogenetics and neuropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3, 6 and 7.
Udo Rüb, Ludger Schöls, Henry Paulson, Georg Auburger, Pawel Kermer, Joanna C Jen, Kay Seidel, Horst-Werner Korf, Thomas Deller. Prog Neurobiol 2013
168
20

Toward understanding Machado-Joseph disease.
Maria do Carmo Costa, Henry L Paulson. Prog Neurobiol 2012
153
20

Antisense oligonucleotide-mediated ataxin-1 reduction prolongs survival in SCA1 mice and reveals disease-associated transcriptome profiles.
Jillian Friedrich, Holly B Kordasiewicz, Brennon O'Callaghan, Hillary P Handler, Carmen Wagener, Lisa Duvick, Eric E Swayze, Orion Rainwater, Bente Hofstra, Michael Benneyworth,[...]. JCI Insight 2018
39
20

Spinal cord damage in Machado-Joseph disease.
Camila N Fahl, Lucas Melo T Branco, Felipe P G Bergo, Anelyssa D'Abreu, Iscia Lopes-Cendes, Marcondes C França. Cerebellum 2015
18
33

Brain white matter damage in SCA1 and SCA2. An in vivo study using voxel-based morphometry, histogram analysis of mean diffusivity and tract-based spatial statistics.
Riccardo Della Nave, Andrea Ginestroni, Carlo Tessa, Elena Salvatore, Domenico De Grandis, Rosaria Plasmati, Fabrizio Salvi, Giuseppe De Michele, Maria Teresa Dotti, Silvia Piacentini,[...]. Neuroimage 2008
66
17

Autosomal dominant cerebellar ataxia type I. MRI-based volumetry of posterior fossa structures and basal ganglia in spinocerebellar ataxia types 1, 2 and 3.
T Klockgether, M Skalej, D Wedekind, A R Luft, D Welte, J B Schulz, M Abele, K Bürk, F Laccone, A Brice,[...]. Brain 1998
129
17

Toward RNAi therapy for the polyglutamine disease Machado-Joseph disease.
Maria do Carmo Costa, Katiuska Luna-Cancalon, Svetlana Fischer, Naila S Ashraf, Michelle Ouyang, Rahil M Dharia, Lucas Martin-Fishman, Yemen Yang, Vikram G Shakkottai, Beverly L Davidson,[...]. Mol Ther 2013
65
17

Test-retest reproducibility of neurochemical profiles with short-echo, single-voxel MR spectroscopy at 3T and 7T.
Melissa Terpstra, Ian Cheong, Tianmeng Lyu, Dinesh K Deelchand, Uzay E Emir, Petr Bednařík, Lynn E Eberly, Gülin Öz. Magn Reson Med 2016
77
17

Assessing recovery from neurodegeneration in spinocerebellar ataxia 1: Comparison of in vivo magnetic resonance spectroscopy with motor testing, gene expression and histology.
Gülin Öz, Emily Kittelson, Döne Demirgöz, Orion Rainwater, Lynn E Eberly, Harry T Orr, H Brent Clark. Neurobiol Dis 2015
11
54

Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational study.
Tetsuo Ashizawa, Karla P Figueroa, Susan L Perlman, Christopher M Gomez, George R Wilmot, Jeremy D Schmahmann, Sarah H Ying, Theresa A Zesiewicz, Henry L Paulson, Vikram G Shakkottai,[...]. Orphanet J Rare Dis 2013
71
17

The preclinical stage of spinocerebellar ataxias.
Roderick P P W M Maas, Judith van Gaalen, Thomas Klockgether, Bart P C van de Warrenburg. Neurology 2015
53
17

Proton magnetic resonance spectroscopy in an Italian family with spinocerebellar ataxia type 1.
M Mascalchi, M Tosetti, R Plasmati, M C Bianchi, C Tessa, F Salvi, M Frontali, F Valzania, C Bartolozzi, C A Tassinari. Ann Neurol 1998
58
17

Differences between spinocerebellar ataxias and multiple system atrophy-cerebellar type on proton magnetic resonance spectroscopy.
Jiing-Feng Lirng, Po-Shan Wang, Hung-Chieh Chen, Bing-Wen Soong, Wan Yuo Guo, Hsiu-Mei Wu, Cheng-Yen Chang. PLoS One 2012
25
24

White matter damage is related to ataxia severity in SCA3.
J-S Kang, J C Klein, S Baudrexel, R Deichmann, D Nolte, R Hilker. J Neurol 2014
27
22

Axonal dysfunction in the deep white matter in Machado-Joseph disease.
Anelyssa D'Abreu, Marcondes França, Simone Appenzeller, Iscia Lopes-Cendes, Fernando Cendes. J Neuroimaging 2009
26
23

Survival in patients with spinocerebellar ataxia types 1, 2, 3, and 6 (EUROSCA): a longitudinal cohort study.
Alhassane Diallo, Heike Jacobi, Arron Cook, Robyn Labrum, Alexandra Durr, Alexis Brice, Perrine Charles, Cecilia Marelli, Caterina Mariotti, Lorenzo Nanetti,[...]. Lancet Neurol 2018
37
17

The merit of proton magnetic resonance spectroscopy in the longitudinal assessment of spinocerebellar ataxias and multiple system atrophy-cerebellar type.
Hung-Chieh Chen, Jiing-Feng Lirng, Bing-Wen Soong, Wan Yuo Guo, Hsiu-Mei Wu, Clayton Chi-Chang Chen, Cheng-Yen Chang. Cerebellum Ataxias 2014
11
54


Spinocerebellar ataxia.
Thomas Klockgether, Caterina Mariotti, Henry L Paulson. Nat Rev Dis Primers 2019
112
17

CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1.
Y Kawaguchi, T Okamoto, M Taniwaki, M Aizawa, M Inoue, S Katayama, H Kawakami, S Nakamura, M Nishimura, I Akiguchi. Nat Genet 1994
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.